These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35387543)
21. Nicotine Component of Cigarette Smoke Extract (CSE) Decreases the Cytotoxicity of CSE in BEAS-2B Cells Stably Expressing Human Cytochrome P450 2A13. Ji M; Zhang Y; Li N; Wang C; Xia R; Zhang Z; Wang SL Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29027939 [TBL] [Abstract][Full Text] [Related]
22. Aromatase inhibition by bioavailable methylated flavones. Ta N; Walle T J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):127-9. PubMed ID: 17624765 [TBL] [Abstract][Full Text] [Related]
23. Novel methoxylated flavone inhibitors of cytochrome P450 1B1 in SCC-9 human oral cancer cells. Walle T; Walle UK J Pharm Pharmacol; 2007 Jun; 59(6):857-62. PubMed ID: 17637178 [TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells. Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115 [TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of methoxyflavonoids on human CYP1B1 activity. Takemura H; Itoh T; Yamamoto K; Sakakibara H; Shimoi K Bioorg Med Chem; 2010 Sep; 18(17):6310-5. PubMed ID: 20696580 [TBL] [Abstract][Full Text] [Related]
26. Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6. Shimada T; Murayama N; Yamazaki H; Tanaka K; Takenaka S; Komori M; Kim D; Guengerich FP Chem Res Toxicol; 2013 Apr; 26(4):529-37. PubMed ID: 23432465 [TBL] [Abstract][Full Text] [Related]
27. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724 [TBL] [Abstract][Full Text] [Related]
28. NADPH- and hydroperoxide-supported 17beta-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1. Spink DC; Spink BC; Zhuo X; Hussain MM; Gierthy JF; Ding X J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):11-8. PubMed ID: 11074351 [TBL] [Abstract][Full Text] [Related]
29. The O-methylation of chrysin markedly improves its intestinal anti-inflammatory properties: Structure-activity relationships of flavones. During A; Larondelle Y Biochem Pharmacol; 2013 Dec; 86(12):1739-46. PubMed ID: 24134915 [TBL] [Abstract][Full Text] [Related]
30. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes. Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964 [TBL] [Abstract][Full Text] [Related]
31. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Wen X; Walle T Drug Metab Dispos; 2006 Oct; 34(10):1786-92. PubMed ID: 16868069 [TBL] [Abstract][Full Text] [Related]
32. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602 [TBL] [Abstract][Full Text] [Related]
33. Analysis of dibenzo[def,p]chrysene-deoxyadenosine adducts in wild-type and cytochrome P450 1b1 knockout mice using stable-isotope dilution UHPLC-MS/MS. Harper TA; Morré J; Lauer FT; McQuistan TJ; Hummel JM; Burchiel SW; Williams DE Mutat Res Genet Toxicol Environ Mutagen; 2015 Apr; 782():51-6. PubMed ID: 25868132 [TBL] [Abstract][Full Text] [Related]
34. Identification of 5-hydroxymethylfurfural in cigarette smoke extract as a new substrate metabolically activated by human cytochrome P450 2A13. Ji M; Zhang Z; Li N; Xia R; Wang C; Yu Y; Yao S; Shen J; Wang SL Toxicol Appl Pharmacol; 2018 Nov; 359():108-117. PubMed ID: 30253172 [TBL] [Abstract][Full Text] [Related]
35. Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression. Cui J; Meng Q; Zhang X; Cui Q; Zhou W; Li S J Med Chem; 2015 Apr; 58(8):3534-47. PubMed ID: 25799264 [TBL] [Abstract][Full Text] [Related]
36. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779 [TBL] [Abstract][Full Text] [Related]
37. A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells. Takemura H; Uchiyama H; Ohura T; Sakakibara H; Kuruto R; Amagai T; Shimoi K J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):70-6. PubMed ID: 19833205 [TBL] [Abstract][Full Text] [Related]
38. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1. Jerabek P; Martinek V; Stiborova M Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840 [TBL] [Abstract][Full Text] [Related]